PPI\u3068\u306fPatient Public Involvement\u306e\u3053\u3068\u3067\u3059\u304c\u3001\u533b\u85ac\u54c1\u306e\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u30fb\u30ea\u30b9\u30af\u8a55\u4fa1\u306b\u304a\u3051\u308b\u60a3\u8005\u30fb\u5e02\u6c11\u306e\u53c2\u753b\u306b\u3064\u3044\u3066EU\u3067\u306f\u304b\u306a\u308a\u8b70\u8ad6\u304c\u9032\u3093\u3067\u3044\u307e\u3059\u3002<\/p>\n\n\n\n
Innovative Medicines Initiative (IMI)<\/a> \u3000IMI2\u671f\u30d7\u30ed\u30b0\u30e9\u30e0\uff082014\uff0d2020\u5e74\uff09\u3092\u901a\u3058\u7d044100\u5104\u5186\uff0833\u5104\u30e6\u30fc\u30ed\uff09\u306e\u4e88\u7b97\u304c\u7528\u610f\u3055\u308c\u307e\u3057\u305f\u3002IMI\u306e\u30b4\u30fc\u30eb\u3001\u7279\u306b\u7b2c2\u671f\uff08IMI2,\u30002014-2020)\u306f\u6b21\u306e\u4e16\u4ee3\u306e\u30ef\u30af\u30c1\u30f3\u3001\u65b0\u3057\u3044\u6297\u751f\u7269\u8cc7\u306e\u3088\u3046\u306a\u3001\u533b\u85ac\u54c1\u3001\u6cbb\u7642\u6cd5\u3092\u958b\u767a\u3059\u308b\u3053\u3068\u3060\u305d\u3046\u3067\u3059\u3002<\/p>\n\n\n\n Pharmacoepidemiological Research on Outcomes of Therapeutics by a European Consortium\u3000(PROTECT)\u00a0<\/a> \u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u3068\u30ea\u30b9\u30af\u3068\u306f\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u3068\u30cf\u30fc\u30e0\u3064\u307e\u308a\u76ca\u3068\u5bb3\u3068\u540c\u3058\u610f\u5473\u3067\u3059\u3002\u8a3a\u7642\u30ac\u30a4\u30c9\u30e9\u30a4\u30f3\u4f5c\u6210\u3067\u4ecb\u5165\u306e\u76ca\u3068\u5bb3\u3092\u30b7\u30b9\u30c6\u30de\u30c6\u30a3\u30c3\u30af\u30ec\u30d3\u30e5\u30fc\u3067\u660e\u3089\u304b\u306b\u3059\u308b\u306e\u3068\u307b\u3068\u3093\u3069\u540c\u3058\u4e8b\u3092\u3059\u308b\u3053\u3068\u306b\u306a\u308a\u307e\u3059\u3002<\/p>\n\n\n\n \u3000PROTECT\u306f34\u306e\u6c11\u9593\u304a\u3088\u3073\u516c\u7684\u30d1\u30fc\u30c8\u30ca\u30fc\u306e\u9593\u306e\u5171\u540c\u4f5c\u696d\u3067\u3042\u308a\u3001\u6b27\u5dde\u533b\u85ac\u54c1\u5c40\u306e\u3082\u3068\u3067\u9023\u643a\u3057\u3066\u3044\u307e\u3059\u3002PROTECT\u3067\u306f\u8a086\u3064\u306e\u30ef\u30fc\u30af\u30d1\u30c3\u30b1\u30fc\u30b8\u304c\u6210\u679c\u3068\u3057\u3066\u767a\u8868\u3055\u308c\u3066\u304a\u308a\u3001\u305d\u308c\u305e\u308c\u7570\u306a\u308b\u9818\u57df\u306b\u7126\u70b9\u304c\u5f53\u3066\u3089\u308c\u3066\u3044\u307e\u3059\u3002<\/p>\n\n\n\n \u3055\u3066\u3001 Patient Public Involvement (PPI)\u306e\u5b9a\u7fa9 Involvement: \u3053\u308c\u3089\u306e\u5b9a\u7fa9\u306f\u30a4\u30ae\u30ea\u30b9\u306eNational Health Service (NHS)\u56fd\u6c11\u5065\u5eb7\u30b5\u30fc\u30d3\u30b9\u306b\u304a\u3051\u308b\u3088\u308a\u591a\u304f\u306e\u5e02\u6c11\u53c2\u52a0\u3092\u30b5\u30dd\u30fc\u30c8\u3057\u3066\u3044\u308b\u5168\u56fd\u898f\u6a21\u306e\u30a2\u30c9\u30d0\u30a4\u30b6\u30ea\u30fc\u30b0\u30eb\u30fc\u30d7\u3067\u3042\u308bInvolve<\/a>\u304b\u3089\u63a1\u7528\u3057\u305f\u305d\u3046\u3067\u3059\u3002<\/p>\n\n\n\n \u3053\u306e\u5831\u544a\u66f8\u3067\u306f\u3001PPI\u304c\u91cd\u8981\u306a\u5834\u9762\u3068\u3057\u3066\u3001a) \u95a2\u9023\u3059\u308b\u30a2\u30a6\u30c8\u30ab\u30e0\u6e2c\u5b9a\u306e\u9078\u629e\u3001\u63a1\u7528\u3001\u9664\u5916<\/strong>\u3001b)\u30a2\u30a6\u30c8\u30ab\u30e0\u6e2c\u5b9a\u306e\u9806\u4f4d\u4ed8\u3051\u3068\u91cd\u307f\u3065\u3051<\/strong>\u3001\u304c\u6319\u3052\u3089\u308c\u3066\u3044\u307e\u3059\u3002For example, PPI may be considered important during (a) the selection, inclusion and exclusion of relevant outcome measures, or (b) the ranking and weighting of outcome measures<\/p>\n","protected":false},"excerpt":{"rendered":" PPI\u3068\u306fPatient Public Involvement\u306e\u3053\u3068\u3067\u3059\u304c\u3001\u533b\u85ac\u54c1\u306e\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u30fb\u30ea\u30b9\u30af\u8a55\u4fa1\u306b\u304a\u3051\u308b\u60a3\u8005\u30fb\u5e02\u6c11\u306e\u53c2\u753b\u306b\u3064\u3044\u3066EU\u3067\u306f\u304b\u306a\u308a\u8b70\u8ad6\u304c\u9032\u3093\u3067\u3044\u307e\u3059\u3002 Innovative Medicines I … “IMI PROTECT\u3068PPI” \u306e<\/span>\u7d9a\u304d\u3092\u8aad\u3080<\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[27,5],"tags":[],"class_list":["post-373","post","type-post","status-publish","format-standard","hentry","category-benefit-harm-assessment","category-cpg"],"_links":{"self":[{"href":"https:\/\/info.zanet.biz\/index.php?rest_route=\/wp\/v2\/posts\/373","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/info.zanet.biz\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/info.zanet.biz\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/info.zanet.biz\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/info.zanet.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=373"}],"version-history":[{"count":7,"href":"https:\/\/info.zanet.biz\/index.php?rest_route=\/wp\/v2\/posts\/373\/revisions"}],"predecessor-version":[{"id":381,"href":"https:\/\/info.zanet.biz\/index.php?rest_route=\/wp\/v2\/posts\/373\/revisions\/381"}],"wp:attachment":[{"href":"https:\/\/info.zanet.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=373"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/info.zanet.biz\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=373"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/info.zanet.biz\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=373"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\u3000Innovative Medicines Initiative (IMI)\u9769\u65b0\u7684\u533b\u85ac\u54c1\u30a4\u30cb\u30b7\u30a2\u30c6\u30a3\u30d6<\/strong>\u306fEU\u3068\u30e8\u30fc\u30ed\u30c3\u30d1\u88fd\u85ac\u4f01\u696d\u306e\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3067\u3059\u3079\u3066\u306e\u4eba\u306e\u5065\u5eb7\u3068\u5e78\u798f\u306e\u305f\u3081\u306e\u500b\u5225\u5316\u533b\u85ac\u306e\u3001\u7279\u306b\u533b\u7642\u30cb\u30fc\u30ba\u306b\u5341\u5206\u5fdc\u3048\u3089\u308c\u3066\u3044\u306a\u3044\u9818\u57df\u3067\u306e\u3001\u958b\u767a\u3068\u305d\u308c\u3089\u3078\u306e\u60a3\u8005\u3055\u3093\u306e\u30a2\u30af\u30bb\u30b9\u3092\u4fc3\u9032\u3059\u308b\u7814\u7a76\u306b\u304a\u3051\u308b\u30aa\u30fc\u30d7\u30f3\u306a\u30b3\u30e9\u30dc\u30ec\u30fc\u30b7\u30e7\u30f3\u3092\u4fc3\u9032\u3059\u308b\u6d3b\u52d5\u3092\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n\n\n\n
\u3000\u6cbb\u7642\u30a2\u30a6\u30c8\u30ab\u30e0\u306b\u95a2\u3059\u308b\u85ac\u5264\u75ab\u5b66\u7684\u7814\u7a76\u30e8\u30fc\u30ed\u30c3\u30d1\u30b3\u30f3\u30bd\u30fc\u30b7\u30a2\u30e0<\/strong>\u306f\u9769\u65b0\u7684\u533b\u85ac\u54c1\u30a4\u30cb\u30b7\u30a2\u30c6\u30a3\u30d6(IMI)\u306e\u4e0b\u3067\u4f5c\u3089\u308c\u305f\u30d7\u30ed\u30b8\u30a7\u30af\u30c8\u3067\u3001\u533b\u85ac\u54c1\u306e\u526f\u4f5c\u7528\u3092\u3055\u307e\u3056\u307e\u306a\u30c7\u30fc\u30bf\u30bd\u30fc\u30b9\u304b\u3089\u65e9\u671f\u306b\u691c\u51fa\u3057\u8a55\u4fa1\u3059\u308b\u3053\u3068\u3092\u4fc3\u9032\u3059\u308b\u4e00\u9023\u306e\u9769\u65b0\u7684\u30c4\u30fc\u30eb\u3068\u65b9\u6cd5\u3092\u958b\u767a\u3057\u3001\u30d9\u30cd\u30d5\u30a3\u30c3\u30c8\u3068\u30ea\u30b9\u30af\u306b\u95a2\u3059\u308b\u30c7\u30fc\u30bf\u306e\u7d71\u5408\u3068\u63d0\u793a\u3092\u53ef\u80fd\u306b\u3059\u308b\u3053\u3068\u3092\u76ee\u7684\u3068\u3057\u3066\u3044\u307e\u3059\u3002<\/p>\n\n\n\n
The patient and public involvement (PPI)<\/strong>\u60a3\u8005\u30fb\u5e02\u6c11\u306e\u53c2\u753b\u306b\u3064\u3044\u3066\u306fWork Package Five (WP5)\u3067\u53d6\u308a\u6271\u308f\u308c\u3066\u3044\u307e\u3059\u3002IMI PROTECT Benefit-Risk Group PAATIENT AND PUBLIC INVOLVEMENT REPORT version 1.0 Recommendations for Patient and Public Involvement in the assessment of benefit and risk of medicines. (Team leader Kimberley Hockley, Imperial college London). (PDF file<\/a>)<\/p>\n\n\n\n
Patient and public:
\u201d\u60a3\u8005\u3068\u5e02\u6c11\u201d\u3068\u306f\u3001\u81e8\u5e8a\u8a66\u9a13\u3078\u306e\u53c2\u52a0\u8005\u3001\u60a3\u8005\u304a\u3088\u3073\u5c06\u6765\u60a3\u8005\u306b\u306a\u308a\u3046\u308b\u8005\u3001\u969c\u5bb3\u8005\u3001\u4e21\u89aa\u3068\u4fdd\u8b77\u8005\u3001\u5065\u5eb7\u30b5\u30fc\u30d3\u30b9\u30fb\u793e\u4f1a\u798f\u7949\u30b5\u30fc\u30d3\u30b9\u306e\u5229\u7528\u8005\u3001\u4ecb\u8b77\u8005\u3001\u4e00\u822c\u5e02\u6c11\u30e1\u30f3\u30d0\u30fc\u3001\u3053\u308c\u3089\u306e\u4eba\u3005\u306e\u5229\u76ca\u3092\u4ee3\u8868\u3059\u308b\u7d44\u7e54\u3002<\/p>\n\n\n\n
\u201d\u53c2\u753b\u201d\u3068\u306f\u3001\u60a3\u8005\u3001\u5e02\u6c11\u3068\u610f\u601d\u6c7a\u5b9a\u306b\u3042\u305f\u308b\u898f\u5236\u5f53\u5c40\u306e\u9593\u306e\u80fd\u52d5\u7684\u306a\u30d1\u30fc\u30c8\u30ca\u30fc\u30b7\u30c3\u30d7\u3067\u3042\u308a\u3001\u60a3\u8005\u3068\u5e02\u6c11\u3092\u610f\u601d\u6c7a\u5b9a\u306e\u5bfe\u8c61\u8005\u3068\u3057\u3066\u6271\u3046\u3053\u3068\u3067\u306f\u306a\u3044\u3002\u60a3\u8005\u30fb\u5e02\u6c11\u306e\u53c2\u753b\u3068\u306f\u60a3\u8005\u30fb\u5e02\u6c11\u3068\u3068\u3082\u306b\u306a\u3055\u308c\u308b\u3042\u308b\u3044\u306f\u60a3\u8005\u30fb\u5e02\u6c11\u306b\u3088\u3063\u3066\u306a\u3055\u308c\u308b\u610f\u601d\u6c7a\u5b9a\u3068\u5b9a\u7fa9\u3055\u308c\u3001\u60a3\u8005\u30fb\u5e02\u6c11\u3078\u3001\u306b\u95a2\u3057\u3066\u3001\u3042\u308b\u3044\u306f\u3001\u306e\u305f\u3081\u306e\u610f\u601d\u6c7a\u5b9a\u3068\u3044\u3046\u610f\u5473\u3067\u306f\u306a\u3044\u3002<\/p>\n\n\n\n